·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.02.18 15:37:04 6 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 70ȸ ±¹½Ã ÇÕ°ÝÀÚ ¸í´Ü ¹ßÇ¥...ÇÕ°Ý·ü 90% ¡ã±¹½Ã ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾ Á¦70ȸ ¾à»ç ±¹°¡½ÃÇèÀ» ÅëÇØ 1896¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÆ´Ù. ¼ö¼®Àº ºÎ»ê´ë ¾à´ë °í¼º¿ø ¾¾(32)°¡ Â÷ÁöÇß´Ù. º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿øÀº 18ÀÏ Áö³´Þ 25ÀÏ ½ÃÇàµÈ ¾à»ç±¹½Ã ½ÃÇè °á°ú, 2106¸íÀÇ ÀÀ½ÃÀÚ Áß 1896¸íÀÌ ÇÕ°ÝÇØ 90%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. ¿ÃÇØ ÇÕ°Ý·üÀº Áö³ÇØ º¸´Ù 1.2% °¨¼ÒÇß´Ù. ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾´Â 350Á¡ ¸¸Á¡¿¡ 336Á¡(96Á¡/100Á¡ ȯ»ê ±âÁØ)À» ȹµæÇß´Ù. ¾à»ç±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr) ¹× ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr) ¶Ç´Â ÇÕ°ÝÀÚ ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · 70ȸ ¾à»ç±¹½Ã ÀÀ½ÃÀÚ 2106¸í...ÀÀ½ÃÀ² 98.9% · "¾à»ç±¹½Ã ³À̵µ Á¶Àý"¡¦ÇÕ°Ý·ü ¼ÒÆø Ç϶ô Àü¸Á · "²À ÇÕ°ÝÇϼ¼¿ä"¡¦¿ª´ë ÃÖ´Ù 2157¸í ÀÀ½Ã ¾à»ç±¹½Ã... · ³»ÀÏ Àü±¹ 5°³ Áö¿ª¼ ¾à»ç±¹½Ã¡¦¿ª´ë ÃÖ´ë 2147¸í... ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â 100¸¸¾à»çÈÀÌÆÃ!! ³Ê¹« Á¶±Ý »Ì´Â°Å ¾Æ´Ñ°¡¿ä?? ÀÌ·¡¼ 100¸¸¾à»ç ¾î´À ¼¼¿ù¿¡ ¸¸µå³ª¿ä?? 1200¸í ³ª¿À´ø°Å ÀÌÁ¦ 2000¸í °¡±îÀÌ ³ª¿À°í, °Å±â¼ ¶Ç ¸î ¹é ¸í ´Ã¸± °èȹÀÌ°í... ¾à»ç ÆÄ¿ö°¡ ¸·°ÇØÁö·Á¸é 100¸¸ ¾à»ç¸¦ Å°¿ö³»¾ß¸¸ ÇÕ´Ï´Ù. 1³â¿¡ ¾à»ç 20¸¸¸í Á¤µµ´Â ¹èÃâÇØ¾ß ÇÏÁö ¾Ê°Ú½À´Ï±î¾Æ!!! 19.02.19 11:17:59 0 ¼öÁ¤ »èÁ¦ 2 4 ±Ùµ¥ ¿½ÉÈ÷ Çؼ ÇÕ°ÝÇÑ°Ç ´ç¿¬ÇÏ°ÚÁö¸¸ ³î°Å ´Ù ³î°í µ¿¾Æ¸® È°µ¿ SNS ´ÙÇÏ°í ÇÕ¼ºÇа°Àº °ú¸ñµé ¹ö¸®°í ±×·¸°Ô Çصµ ¾ÈÁ¤ÀûÀ¸·Î ÇÕ°ÝÇÒ ¼ö ÀÖ´Â ±¸Á¶´Â.......... ¿µ¿ªº° °ú¶ôÀÌ ¾Æ´Ñ °ú¸ñº° °ú¶ôÀ» Ãß°¡Çؼ ÇÕ°Ý·ü Á» Á¶Á¤ÇßÀ¸¸é ÁÁ°ÚÀ½ 19.02.18 20:08:24 0 ¼öÁ¤ »èÁ¦ 11 10 ¤·¤·¤· ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ 19.02.18 19:03:15 0 ¼öÁ¤ »èÁ¦ 4 2 ¤·¤·¤· ¾à»ç°¡ ´ë¼öÀÓ? ÀÇ·áÀεµ ¾Æ´Ñ°ÍµéÀÌ ¤»¤» Æò»ý¸Ô°í»ìÁپ˾ÒÁö? 19.02.18 17:45:12 2 ¼öÁ¤ »èÁ¦ 2 11 ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø¸¸µé¸é ¾à»ç ´Ù°°ÀÌ Á״°ŴÙ. ³»³â ¶Ç 100¸í Áõ¿øµÇ´Âµ¥ ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø ¸¸µé¸é ±×³É ´Ù°°ÀÌ Á״°ŴÙ. º¯½Ãó·³ 50%ÀÌÇÏ·Î ¸¸µé¾î¾ß ÇÑ´Ù. ±×·¡¾ß ´Ù°°ÀÌ »ê´Ù. 19.02.18 16:11:45 0 ¼öÁ¤ »èÁ¦ 13 11 ¤»¤» ÇÍÃæÀÌ °³ºý´ë°¡¸®µé ÇÕ°ÝÀ²ÀÌ 90%.......¤¶`¤² 4³âÁ¦ ¾à»çµéµµ ÇÕ°ÝÀ²ÀÌ 80%¿´´Âµ¥...... Á¤¸» ¾à»ç °³Àæ¸ÁÀÌ´Ù. ¤¶`¤².............. 19.02.18 16:03:55 1 ¼öÁ¤ »èÁ¦ 14 19 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.02.18 15:37:04 6 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 70ȸ ±¹½Ã ÇÕ°ÝÀÚ ¸í´Ü ¹ßÇ¥...ÇÕ°Ý·ü 90% ¡ã±¹½Ã ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾ Á¦70ȸ ¾à»ç ±¹°¡½ÃÇèÀ» ÅëÇØ 1896¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÆ´Ù. ¼ö¼®Àº ºÎ»ê´ë ¾à´ë °í¼º¿ø ¾¾(32)°¡ Â÷ÁöÇß´Ù. º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿øÀº 18ÀÏ Áö³´Þ 25ÀÏ ½ÃÇàµÈ ¾à»ç±¹½Ã ½ÃÇè °á°ú, 2106¸íÀÇ ÀÀ½ÃÀÚ Áß 1896¸íÀÌ ÇÕ°ÝÇØ 90%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. ¿ÃÇØ ÇÕ°Ý·üÀº Áö³ÇØ º¸´Ù 1.2% °¨¼ÒÇß´Ù. ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾´Â 350Á¡ ¸¸Á¡¿¡ 336Á¡(96Á¡/100Á¡ ȯ»ê ±âÁØ)À» ȹµæÇß´Ù. ¾à»ç±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr) ¹× ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr) ¶Ç´Â ÇÕ°ÝÀÚ ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · 70ȸ ¾à»ç±¹½Ã ÀÀ½ÃÀÚ 2106¸í...ÀÀ½ÃÀ² 98.9% · "¾à»ç±¹½Ã ³À̵µ Á¶Àý"¡¦ÇÕ°Ý·ü ¼ÒÆø Ç϶ô Àü¸Á · "²À ÇÕ°ÝÇϼ¼¿ä"¡¦¿ª´ë ÃÖ´Ù 2157¸í ÀÀ½Ã ¾à»ç±¹½Ã... · ³»ÀÏ Àü±¹ 5°³ Áö¿ª¼ ¾à»ç±¹½Ã¡¦¿ª´ë ÃÖ´ë 2147¸í... ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ÇԾȰøÀå Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â 100¸¸¾à»çÈÀÌÆÃ!! ³Ê¹« Á¶±Ý »Ì´Â°Å ¾Æ´Ñ°¡¿ä?? ÀÌ·¡¼ 100¸¸¾à»ç ¾î´À ¼¼¿ù¿¡ ¸¸µå³ª¿ä?? 1200¸í ³ª¿À´ø°Å ÀÌÁ¦ 2000¸í °¡±îÀÌ ³ª¿À°í, °Å±â¼ ¶Ç ¸î ¹é ¸í ´Ã¸± °èȹÀÌ°í... ¾à»ç ÆÄ¿ö°¡ ¸·°ÇØÁö·Á¸é 100¸¸ ¾à»ç¸¦ Å°¿ö³»¾ß¸¸ ÇÕ´Ï´Ù. 1³â¿¡ ¾à»ç 20¸¸¸í Á¤µµ´Â ¹èÃâÇØ¾ß ÇÏÁö ¾Ê°Ú½À´Ï±î¾Æ!!! 19.02.19 11:17:59 0 ¼öÁ¤ »èÁ¦ 2 4 ±Ùµ¥ ¿½ÉÈ÷ Çؼ ÇÕ°ÝÇÑ°Ç ´ç¿¬ÇÏ°ÚÁö¸¸ ³î°Å ´Ù ³î°í µ¿¾Æ¸® È°µ¿ SNS ´ÙÇÏ°í ÇÕ¼ºÇа°Àº °ú¸ñµé ¹ö¸®°í ±×·¸°Ô Çصµ ¾ÈÁ¤ÀûÀ¸·Î ÇÕ°ÝÇÒ ¼ö ÀÖ´Â ±¸Á¶´Â.......... ¿µ¿ªº° °ú¶ôÀÌ ¾Æ´Ñ °ú¸ñº° °ú¶ôÀ» Ãß°¡Çؼ ÇÕ°Ý·ü Á» Á¶Á¤ÇßÀ¸¸é ÁÁ°ÚÀ½ 19.02.18 20:08:24 0 ¼öÁ¤ »èÁ¦ 11 10 ¤·¤·¤· ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ 19.02.18 19:03:15 0 ¼öÁ¤ »èÁ¦ 4 2 ¤·¤·¤· ¾à»ç°¡ ´ë¼öÀÓ? ÀÇ·áÀεµ ¾Æ´Ñ°ÍµéÀÌ ¤»¤» Æò»ý¸Ô°í»ìÁپ˾ÒÁö? 19.02.18 17:45:12 2 ¼öÁ¤ »èÁ¦ 2 11 ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø¸¸µé¸é ¾à»ç ´Ù°°ÀÌ Á״°ŴÙ. ³»³â ¶Ç 100¸í Áõ¿øµÇ´Âµ¥ ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø ¸¸µé¸é ±×³É ´Ù°°ÀÌ Á״°ŴÙ. º¯½Ãó·³ 50%ÀÌÇÏ·Î ¸¸µé¾î¾ß ÇÑ´Ù. ±×·¡¾ß ´Ù°°ÀÌ »ê´Ù. 19.02.18 16:11:45 0 ¼öÁ¤ »èÁ¦ 13 11 ¤»¤» ÇÍÃæÀÌ °³ºý´ë°¡¸®µé ÇÕ°ÝÀ²ÀÌ 90%.......¤¶`¤² 4³âÁ¦ ¾à»çµéµµ ÇÕ°ÝÀ²ÀÌ 80%¿´´Âµ¥...... Á¤¸» ¾à»ç °³Àæ¸ÁÀÌ´Ù. ¤¶`¤².............. 19.02.18 16:03:55 1 ¼öÁ¤ »èÁ¦ 14 19 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.02.18 15:37:04 6 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 70ȸ ±¹½Ã ÇÕ°ÝÀÚ ¸í´Ü ¹ßÇ¥...ÇÕ°Ý·ü 90% ¡ã±¹½Ã ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾ Á¦70ȸ ¾à»ç ±¹°¡½ÃÇèÀ» ÅëÇØ 1896¸íÀÇ »õ³»±â ¾à»ç°¡ ¹èÃâµÆ´Ù. ¼ö¼®Àº ºÎ»ê´ë ¾à´ë °í¼º¿ø ¾¾(32)°¡ Â÷ÁöÇß´Ù. º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿øÀº 18ÀÏ Áö³´Þ 25ÀÏ ½ÃÇàµÈ ¾à»ç±¹½Ã ½ÃÇè °á°ú, 2106¸íÀÇ ÀÀ½ÃÀÚ Áß 1896¸íÀÌ ÇÕ°ÝÇØ 90%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. ¿ÃÇØ ÇÕ°Ý·üÀº Áö³ÇØ º¸´Ù 1.2% °¨¼ÒÇß´Ù. ¼ö¼®À» Â÷ÁöÇÑ °í¼º¿ø ¾¾´Â 350Á¡ ¸¸Á¡¿¡ 336Á¡(96Á¡/100Á¡ ȯ»ê ±âÁØ)À» ȹµæÇß´Ù. ¾à»ç±¹½Ã ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr) ¹× ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr) ¶Ç´Â ÇÕ°ÝÀÚ ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡°Ô ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤ÀÌ´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · 70ȸ ¾à»ç±¹½Ã ÀÀ½ÃÀÚ 2106¸í...ÀÀ½ÃÀ² 98.9% · "¾à»ç±¹½Ã ³À̵µ Á¶Àý"¡¦ÇÕ°Ý·ü ¼ÒÆø Ç϶ô Àü¸Á · "²À ÇÕ°ÝÇϼ¼¿ä"¡¦¿ª´ë ÃÖ´Ù 2157¸í ÀÀ½Ã ¾à»ç±¹½Ã... · ³»ÀÏ Àü±¹ 5°³ Áö¿ª¼ ¾à»ç±¹½Ã¡¦¿ª´ë ÃÖ´ë 2147¸í...
100¸¸¾à»çÈÀÌÆÃ!! ³Ê¹« Á¶±Ý »Ì´Â°Å ¾Æ´Ñ°¡¿ä?? ÀÌ·¡¼ 100¸¸¾à»ç ¾î´À ¼¼¿ù¿¡ ¸¸µå³ª¿ä?? 1200¸í ³ª¿À´ø°Å ÀÌÁ¦ 2000¸í °¡±îÀÌ ³ª¿À°í, °Å±â¼ ¶Ç ¸î ¹é ¸í ´Ã¸± °èȹÀÌ°í... ¾à»ç ÆÄ¿ö°¡ ¸·°ÇØÁö·Á¸é 100¸¸ ¾à»ç¸¦ Å°¿ö³»¾ß¸¸ ÇÕ´Ï´Ù. 1³â¿¡ ¾à»ç 20¸¸¸í Á¤µµ´Â ¹èÃâÇØ¾ß ÇÏÁö ¾Ê°Ú½À´Ï±î¾Æ!!! 19.02.19 11:17:59 0 ¼öÁ¤ »èÁ¦ 2 4 ±Ùµ¥ ¿½ÉÈ÷ Çؼ ÇÕ°ÝÇÑ°Ç ´ç¿¬ÇÏ°ÚÁö¸¸ ³î°Å ´Ù ³î°í µ¿¾Æ¸® È°µ¿ SNS ´ÙÇÏ°í ÇÕ¼ºÇа°Àº °ú¸ñµé ¹ö¸®°í ±×·¸°Ô Çصµ ¾ÈÁ¤ÀûÀ¸·Î ÇÕ°ÝÇÒ ¼ö ÀÖ´Â ±¸Á¶´Â.......... ¿µ¿ªº° °ú¶ôÀÌ ¾Æ´Ñ °ú¸ñº° °ú¶ôÀ» Ãß°¡Çؼ ÇÕ°Ý·ü Á» Á¶Á¤ÇßÀ¸¸é ÁÁ°ÚÀ½ 19.02.18 20:08:24 0 ¼öÁ¤ »èÁ¦ 11 10 ¤·¤·¤· ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ ²ÙÁØÈ÷ °¨¼ÒÇÏ°íÀÖ³× ±×·¡µµ 19.02.18 19:03:15 0 ¼öÁ¤ »èÁ¦ 4 2 ¤·¤·¤· ¾à»ç°¡ ´ë¼öÀÓ? ÀÇ·áÀεµ ¾Æ´Ñ°ÍµéÀÌ ¤»¤» Æò»ý¸Ô°í»ìÁپ˾ÒÁö? 19.02.18 17:45:12 2 ¼öÁ¤ »èÁ¦ 2 11 ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø¸¸µé¸é ¾à»ç ´Ù°°ÀÌ Á״°ŴÙ. ³»³â ¶Ç 100¸í Áõ¿øµÇ´Âµ¥ ÇÕ°ÝÀ² 80%ÀÌÇÏ·Î ¸ø ¸¸µé¸é ±×³É ´Ù°°ÀÌ Á״°ŴÙ. º¯½Ãó·³ 50%ÀÌÇÏ·Î ¸¸µé¾î¾ß ÇÑ´Ù. ±×·¡¾ß ´Ù°°ÀÌ »ê´Ù. 19.02.18 16:11:45 0 ¼öÁ¤ »èÁ¦ 13 11 ¤»¤» ÇÍÃæÀÌ °³ºý´ë°¡¸®µé ÇÕ°ÝÀ²ÀÌ 90%.......¤¶`¤² 4³âÁ¦ ¾à»çµéµµ ÇÕ°ÝÀ²ÀÌ 80%¿´´Âµ¥...... Á¤¸» ¾à»ç °³Àæ¸ÁÀÌ´Ù. ¤¶`¤².............. 19.02.18 16:03:55 1 ¼öÁ¤ »èÁ¦ 14 19 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : »õ³»±â¾à»ç 1896¸í ¹èÃ⡦ºÎ»ê¾à´ë °í¼º¿ø ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö